Aizon Launches GxP-Compliant Data Processing Solution to Accelerate Digital Transformation in Life Science Manufacturing

SAN FRANCISCO–(BUSINESS WIRE)–Aizon today announced the launch of its new GxP-compliant data processing product, Aizon Digitize. Digitize provides life science manufacturers with a solution to help them drive their digital transformation, increasing productivity and avoiding time-consuming and error-prone data entry.

Aizon Digitize automatically uploads paper records and commonly used file formats to begin building an audit trail and immediately tracks changes to data, and integrates with eBR, LIMS, QMS, and Manufacturing Execution Systems (MES), to provide powerful information. This previously inaccessible data can now be used to make timely decisions to increase productivity and reduce costs. Digitization is the first step towards realizing the full potential of applying Pharma 4.0 technologies to solve the most common to the most complex manufacturing problems.

The life sciences industry is accelerating the adoption of Pharma 4.0 technologies to meet the need to increase quality and capacity, requiring a massive transformation in the way drugs and vaccines are manufactured. Additionally, increasing competition and improving regulatory guidelines are shifting the investment priorities of pharmaceutical companies to focus on optimizing existing manufacturing processes. With approximately 30% of available data being leveraged to improve these processes, manufacturers have a tremendous opportunity to create a holistic view of their operations and shift to predictive operation, offering much greater insights to empower users to make better decisions. timely and more accurate.

“Many pharmaceutical manufacturers still rely on manual input and processes to complete critical tasks. This very common approach exponentially increases the risk of introducing errors and hampering their ability to optimize the entire development and manufacturing process,” said John VItalie, CEO of Aizon. “Aizon Digitize helps users avoid unnecessary manual entry and transfer of information that can create volumes of erroneous data leading to increasing levels of risk. By shifting the manual workload to an automated digital process, our customers can leverage all the valuable data trapped in paper-based folders and spreadsheets.It’s the on-ramp to realizing the benefits that compliant Pharma 4.0 technology can bring to any biopharmaceutical manufacturing operation.

Moving from paper to digital information

Aizon’s Digitize uses manual and spreadsheet-based processes and enables digital storage and validation of data through optical character recognition (OCR) and forms-based data entry. Through the digitization of data, organizations can take the first step towards the paradigm of a fully adaptive factory.

With Aizon Digitize, organizations can ingest multiple types of data and store them securely in the cloud, including handwritten data, PDFs, and spreadsheets. Digitize provides both custom and dynamic forms that enable form-based data entry. Users receive confirmation that the form input matches the expected type of data, which they can save to 21 CFR Part 11 compliant records.

About Aizon

Aizon is an AI software provider that transforms manufacturing operations through the use of advanced analytics, artificial intelligence and other smart factory technologies focused on optimizing production in highly regulated. The Aizon AI platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Aizon provides an intuitive way to achieve meaningful operational intelligence by enabling real-time visibility and predictive insights in a GxP-compliant manner with end-to-end data integrity.

For more information, please visit Aizon.ai

Comments are closed.